- Home
- RPTX vs RDIB Comparison
RPTX vs RDIB Comparison
Compare RPTX & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- RDIB
- Stock Information
- Founded
- RPTX 2016
- RDIB 1937
- Country
- RPTX Canada
- RDIB United States
- Employees
- RPTX N/A
- RDIB N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- RDIB Movies/Entertainment
- Sector
- RPTX Health Care
- RDIB Consumer Discretionary
- Exchange
- RPTX Nasdaq
- RDIB Nasdaq
- Market Cap
- RPTX 155.4M
- RDIB 162.8M
- IPO Year
- RPTX 2020
- RDIB N/A
- Fundamental
- Price
- RPTX $3.59
- RDIB $7.64
- Analyst Decision
- RPTX Strong Buy
- RDIB
- Analyst Count
- RPTX 1
- RDIB 0
- Target Price
- RPTX $10.00
- RDIB N/A
- AVG Volume (30 Days)
- RPTX 71.8K
- RDIB 13.3K
- Earning Date
- RPTX 11-07-2024
- RDIB 11-19-2024
- Dividend Yield
- RPTX N/A
- RDIB N/A
- EPS Growth
- RPTX N/A
- RDIB N/A
- EPS
- RPTX N/A
- RDIB N/A
- Revenue
- RPTX $68,683,000.00
- RDIB $203,744,000.00
- Revenue This Year
- RPTX $16.85
- RDIB N/A
- Revenue Next Year
- RPTX N/A
- RDIB $13.64
- P/E Ratio
- RPTX N/A
- RDIB N/A
- Revenue Growth
- RPTX N/A
- RDIB N/A
- 52 Week Low
- RPTX $2.71
- RDIB $5.97
- 52 Week High
- RPTX $8.49
- RDIB $21.34
- Technical
- Relative Strength Index (RSI)
- RPTX 53.00
- RDIB 52.67
- Support Level
- RPTX $3.37
- RDIB $6.70
- Resistance Level
- RPTX $4.05
- RDIB $7.70
- Average True Range (ATR)
- RPTX 0.26
- RDIB 0.48
- MACD
- RPTX 0.00
- RDIB 0.13
- Stochastic Oscillator
- RPTX 40.65
- RDIB 76.28
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.